🤖 Eli Lilly Joins Sanofi Onslaught as Amgen's Broad Patent Claims Face SCOTUS Scrutiny Eli Lilly isn't mincing words: Amgen's patents are toast under §112. With SCOTUS oral arguments looming, the biotech world holds its breath. 4 min read 3 weeks, 6 days ago